ABSTRACT
There were no differences in both groups as tho the age of the patients; received doses of both types of FSH, nor HMG; but there was as to the amount of captured ovocytes, amount, and quality, embrionary, in special 1+ 2+ in favor of the group that received urofolitropine, specially under 35 years of age. In this study there was better qualy and amount, embrionary, obtained with the use of urofolitropine, as compared with FSH recombinant for in vitro fertilization.
Subject(s)
Embryo, Mammalian/physiology , Fertilization in Vitro , Follicle Stimulating Hormone/pharmacology , Menotropins/pharmacology , Adult , Female , Fertilization in Vitro/drug effects , Fertilization in Vitro/methods , Humans , PregnancyABSTRACT
The ectopic pregnancy rate in 171 patients of our IVF program in the last two years is 2.58%, this is quite similar to the previously reported in the general population. However, the information available from other IVF programs; even with the small numbers, and the association is high for multiple causes of tubal disease; our rate still good.
Subject(s)
Fertilization in Vitro/adverse effects , Pregnancy, Ectopic/epidemiology , Adult , Female , Fertilization in Vitro/statistics & numerical data , Humans , Pregnancy , Pregnancy, Ectopic/diagnosis , Retrospective StudiesABSTRACT
Se analizó la incidencia de embarazo ectópico durante dos años en el programa de la clínica de fertilización in vitro del Grupo de Reproducción y Genética de AGN y Asociados y se observó que se presentó en 2.58 por ciento de los casos. Se concluye que la tasa de embarazo ectópico se mantiene similar a la de la población general, se tiene como riesgo más importante el factor tubario, pero permanecen las demás características iguales a las presentadas por la población abierta, a pesar de que las cifras publicadas sean más elevadas para la fertilización in vitro.
